Is HCP Plastene overvalued or undervalued?

As of 20 June 2025, HCP Plastene's valuation grade has moved from attractive to very attractive, indicating a positive shift in its market perception. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE Ratio of 18.95, an EV to EBITDA of 10.48, and a PEG Ratio of 0.02, which suggests strong growth potential relative to its price.
In comparison to its peers, HCP Plastene's valuation stands out favorably; for instance, Garware Hi Tech is deemed very expensive with a PE of 28.07, while AGI Greenpac, also very attractive, has a lower PE of 15.64. This positions HCP Plastene as a compelling investment opportunity in the packaging industry. Despite a recent decline in stock price, the company's strong performance over the past five years, with a return of 4646.48%, reinforces its undervalued status in the current market.